Загрузка...
Nonparametric Benefit–Risk Assessment Using Marker Process in the Presence of a Terminal Event
Benefit–risk assessment is a crucial step in medical decision process. In many biomedical studies, both longitudinal marker measurements and time to a terminal event serve as important endpoints for benefit–risk assessment. The effect of an intervention or a treatment on the longitudinal marker proc...
Сохранить в:
| Опубликовано в: : | J Am Stat Assoc |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935274/ https://ncbi.nlm.nih.gov/pubmed/29731529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01621459.2016.1180988 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|